期刊
LEUKEMIA RESEARCH
卷 34, 期 6, 页码 698-699出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.leukres.2009.12.009
关键词
Chronic myeloid leukemia; Pharmacokinetics; Pharmacodynamics; Therapeutic drug monitoring; Prognostic factors; Imatinib; Nilotinib